uce
ProgressImage ProgressImage
Tyche Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 532384 border-img ISIN Demat INE443B01012 border-img Book Value 117.62 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap ( Cr.) 201.16 border-img P/E 14.12 border-img EPS 13.9 border-img Face Value 10
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales22.2216.0417.05
Other Operating Income0.000.000.00
Other Income 1.511.531.29
Total Income23.7417.5618.34
Total Expenditure 17.3912.9014.25
PBIDT6.344.664.09
Interest 0.000.000.00
PBDT6.344.664.09
Depreciation0.480.470.46
Tax1.601.080.94
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.03-0.02-0.03
Reported Profit After Tax4.293.142.71
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item4.293.142.71
    
EPS (Unit Curr.)4.183.062.65
EPS (Adj) (Unit Curr.)4.183.062.65
Calculated EPS (Unit Curr.)4.183.062.65
Calculated EPS (Adj) (Unit Curr.)4.183.062.65
Calculated EPS (Ann.) (Unit Curr.)16.7412.2610.60
Calculated EPS (Adj) (Ann.) (Unit Curr.)16.7412.2610.60
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.2510.2510.25
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)28.5329.0523.99
PBDTM(%)28.5329.0523.99
PATM(%)19.3119.5815.89
x
x
×
Let's Chat
close
refresh